1.The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro.
Jong Soo LEE ; Young Hi KIM ; Young Min PARK
Journal of Korean Medical Science 2015;30(12):1856-1864
This study investigated the toxicity of commercial non-steroid anti-inflammatory drug (NSAID) eye solutions against corneal epithelial cells in vitro. The biologic effects of 1/100-, 1/50-, and 1/10-diluted bromfenac sodium, pranoprofen, diclofenac sodium, and the fluorometholone on corneal epithelial cells were evaluated after 1-, 4-, 12-, and 24-hr of exposure compared to corneal epithelial cell treated with balanced salt solution as control. Cellular metabolic activity, cellular damage, and morphology were assessed. Corneal epithelial cell migration was quantified by the scratch-wound assay. Compared to bromfenac and pranoprofen, the cellular metabolic activity of diclofenac and fluorometholone significantly decreased after 12-hr exposure, which was maintained for 24-hr compared to control. Especially, at 1/10-diluted eye solution for 24-hr exposure, the LDH titers of fluorometholone and diclofenac sodium markedly increased more than those of bromfenac and pranoprofen. In diclofenac sodium, the Na+ concentration was lower and amount of preservatives was higher than other NSAIDs eye solutions tested. However, the K+ and Cl- concentration, pH, and osmolarity were similar for all NSAIDs eye solutions. Bromfenac and pranoprofen significantly promoted cell migration, and restored wound gap after 48-hr exposure, compared with that of diclofenac or fluorometholone. At 1/50-diluted eye solution for 48-hr exposure, the corneal epithelial cellular morphology of diclofenac and fluorometholone induced more damage than that of bromfenac or pranoprofen. Overall, the corneal epithelial cells in bromfenac and pranoprofen NSAID eye solutions are less damaged compared to those in diclofenac, included fluorometholone as steroid eye solution.
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage/*toxicity
;
Benzophenones/administration & dosage/toxicity
;
Benzopyrans/administration & dosage/toxicity
;
Bromobenzenes/administration & dosage/toxicity
;
Cell Movement/drug effects
;
Cells, Cultured
;
Diclofenac/administration & dosage/toxicity
;
Epithelial Cells/drug effects/metabolism/ultrastructure
;
Epithelium, Corneal/cytology/*drug effects/metabolism
;
Fluorometholone/administration & dosage/toxicity
;
Humans
;
L-Lactate Dehydrogenase/metabolism
;
Microscopy, Electron, Transmission
;
Ophthalmic Solutions
;
Propionates/administration & dosage/toxicity
2.The Role of Nitric Oxide in Ocular Surface Cells.
Jae Chan KIM ; Gun Sic PARK ; Jin Kook KIM ; Young Myeong KIM
Journal of Korean Medical Science 2002;17(3):389-394
The role of nitric oxide (NO) in the ocular surface remains unknown. We investigated the conditions leading to an increase of NO generation in tear and the main sources of NO in ocular surface tissue. We evaluated the dual action (cell survival or cell death) of NO depending on its amount. We measured the concentration of nitrite plus nitrate in the tears of ocular surface diseases and examined the main source of nitric oxide synthase (NOS). When cultured human corneal fibroblast were treated with NO producing donor with or without serum, the viabilities of cells was studied. We found that the main sources of NO in ocular surface tissue were corneal epithelium, fibroblast, endothelium, and inflammatory cells. Three forms of NOS (eNOS, bNOS, and iNOS) were expressed in experimentally induced inflammation. In the fibroblast culture system, the NO donor (SNAP, S-nitroso-N-acetyl-D, L-penicillamine) prevented the death of corneal fibroblast cells caused by serum deprivation in a dose dependent manner up to 500 micrometer SNAP, but a higher dose decreased cell viability. This study suggested that NO might act as a doubleedged sword in ocular surface diseases depending on the degree of inflammation related with NO concentration.
Animals
;
Apoptosis/drug effects/physiology
;
Aqueous Humor/metabolism
;
Blood Proteins/pharmacology
;
Cell Survival/drug effects/physiology
;
Cells, Cultured
;
Epithelium, Corneal/*cytology/*enzymology
;
Fibroblasts/cytology/enzymology
;
Humans
;
Nitric Oxide/biosynthesis/*physiology
;
Nitric Oxide Donors/pharmacology
;
Nitric Oxide Synthase/metabolism
;
Nitric Oxide Synthase Type I
;
Nitric Oxide Synthase Type II
;
Nitric Oxide Synthase Type III
;
Penicillamine/*analogs & derivatives/pharmacology
;
Peroxynitrous Acid/biosynthesis
;
Rabbits
;
Tears/metabolism
;
Uveitis/metabolism